Retraction Note: Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
- PMID: 38811545
- PMCID: PMC11137002
- DOI: 10.1038/s41389-024-00520-7
Retraction Note: Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
Retraction of
-
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas.Oncogenesis. 2018 Jun 19;7(6):47. doi: 10.1038/s41389-018-0059-1. Oncogenesis. 2018. Retraction in: Oncogenesis. 2024 May 29;13(1):19. doi: 10.1038/s41389-024-00520-7. PMID: 29915281 Free PMC article. Retracted.
Similar articles
-
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas.Oncogenesis. 2018 Jun 19;7(6):47. doi: 10.1038/s41389-018-0059-1. Oncogenesis. 2018. Retraction in: Oncogenesis. 2024 May 29;13(1):19. doi: 10.1038/s41389-024-00520-7. PMID: 29915281 Free PMC article. Retracted.
-
Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.J Bone Oncol. 2019 Mar 19;16:100231. doi: 10.1016/j.jbo.2019.100231. eCollection 2019 Jun. J Bone Oncol. 2019. PMID: 30956944 Free PMC article. Review.
-
Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.Clin Orthop Relat Res. 2020 Nov;478(11):2461-2476. doi: 10.1097/CORR.0000000000001322. Clin Orthop Relat Res. 2020. PMID: 32567826 Free PMC article.
-
Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.Ann Surg Oncol. 2011 Oct;18(10):2841-50. doi: 10.1245/s10434-011-1640-4. Epub 2011 Mar 16. Ann Surg Oncol. 2011. PMID: 21409488
-
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas.Crit Rev Oncol Hematol. 2017 Oct;118:1-6. doi: 10.1016/j.critrevonc.2017.06.006. Epub 2017 Jul 15. Crit Rev Oncol Hematol. 2017. PMID: 28917265 Review.
References
Publication types
LinkOut - more resources
Full Text Sources